Johnson & Johnson, Raytheon, Merck and 3M (Photos: Shutterstock.com)

A long list of biotech and pharmaceutical companies, industrials, universities and individual inventors have written to House and Senate Judiciary committee leaders, asking them to support the U.S. Patent and Trademark Office's efforts to trim back administrative patent validity challenges in deference to rocket docket district court litigation.